Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

February 1, 1989; Volume 30,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Martin, Gary V.

    1. You have access
      Enhanced Binding of the Hypoxic Cell Marker [3H]Fluoromisonidazole in Ischemic Myocardium
      Gary V. Martin, James H. Caldwell, Janet S. Rasey, Zdenka Grunbaum, Manuel Cerqueira and Kenneth A. Krohn
      Journal of Nuclear Medicine February 1, 1989, 30 (2) 194-201;
  2. Mcdougall, I. Ross

    1. You have access
      Hyperthyroidism with Low Radioiodine Uptake After Head and Neck Irradiation for Hodgkin's Disease
      Margaret Petersen, Christine A. Keeling and I. Ross McDougall
      Journal of Nuclear Medicine February 1, 1989, 30 (2) 255-257;
  3. Mintun, Mark A.

    1. You have access
      Noninvasive Functional Brain Mapping by Change-Distribution Analysis of Averaged PET Images of H215O Tissue Activity
      Peter T. Fox and Mark A. Mintun
      Journal of Nuclear Medicine February 1, 1989, 30 (2) 141-149;
  4. Mistry, Raman

    1. You have access
      Technetium-99m (v) Dimercaptosuccinic Acid Uptake in Patients with Head and Neck Squamous Carcinoma: Experience in Imaging
      John C. Watkinson, Colin R. Lazarus, Raman Mistry, Omar H. Shaheen, Michael N. Maisey and Susan E. Clarke
      Journal of Nuclear Medicine February 1, 1989, 30 (2) 174-180;
  5. Miyoshi, Toshihiko

    1. You have access
      Regional Dynamics of N-Isopropyl-(123I)p-iodo-Amphetamine in Human Brain
      Sadahiko Nishizawa, Shuji Tanada, Yoshiharu Yonekura, Toru Fujita, Takao Mukai, Hideo Saji, Hidenao Fukuyama, Toshihiko Miyoshi, Kiyoshi Harada, Masatsune Ishikawa, Haruhiko Kikuchi and Junji Konishi
      Journal of Nuclear Medicine February 1, 1989, 30 (2) 150-156;
  6. Mizuno, Takeo

    1. You have access
      Gastrointestinal Visualization During Xenon-133 Ventilation Study in a Patient with Tracheoesophageal Fistula
      Yasuo Takehara, Motoichiro Takahashi, Haruo Isoda, Hiroshi Niwa, Takeo Mizuno and Masao Kaneko
      Journal of Nuclear Medicine February 1, 1989, 30 (2) 258-259;
  7. Morgan, A. Charles

    1. You have access
      Development of a Stable Radioiodinating Reagent to Label Monoclonal Antibodies for Radiotherapy of Cancer
      D. Scott Wilbur, Stephen W. Hadley, Mark D. Hylarides, Paul G. Abrams, Paul A. Beaumier, A. Charles Morgan, John M. Reno and Alan R. Fritzberg
      Journal of Nuclear Medicine February 1, 1989, 30 (2) 216-226;
  8. Moskovitz, Boaz

    1. You have access
      Quantitation of Renal Uptake of Technetium-99m DMSA Using SPECT
      David Groshar, Alex Frankel, Galina Iosilevsky, Ora Israel, Boaz Moskovitz, Dan R. Levin and Dov Front
      Journal of Nuclear Medicine February 1, 1989, 30 (2) 246-250;
  9. Mukai, Takao

    1. You have access
      Regional Dynamics of N-Isopropyl-(123I)p-iodo-Amphetamine in Human Brain
      Sadahiko Nishizawa, Shuji Tanada, Yoshiharu Yonekura, Toru Fujita, Takao Mukai, Hideo Saji, Hidenao Fukuyama, Toshihiko Miyoshi, Kiyoshi Harada, Masatsune Ishikawa, Haruhiko Kikuchi and Junji Konishi
      Journal of Nuclear Medicine February 1, 1989, 30 (2) 150-156;
  10. Myears, Donald W.

    1. You have access
      Validity of Estimates of Myocardial Oxidative Metabolism with Carbon-11 Acetate and Positron Emission Tomography Despite Altered Patterns of Substrate Utilization
      Michael A. Brown, Donald W. Myears and Steven R. Bergmann
      Journal of Nuclear Medicine February 1, 1989, 30 (2) 187-193;
« Previous (Pages : 3 4 5 6 7 8 9 10 11 ... 11) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine
Vol. 30, Issue 2
February 1, 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire